Category & trade
Primary
pharmaceutical-industry · embed-ft 0.36
Tree path
Business and Finance › Industries › Pharmaceutical Industry
Group (tier-1)
Also (top-3)
Tech stack
AI readiness
AI training policy
allowed
Terms of Service
found · https://immunomet.com/terms
AI-bot protection
AI files
Compliance (GEO / GDPR)
TLD
Overview
Title
ImmunoMet Therapeutics | Developing Novel Cancer Drugs by Targeting Metabolism
Description
ImmunoMet Therapeutics is a clinical-stage oncology company developing lixumistat (IM156), a best-in-class OxPhos inhibitor targeting the metabolic dependency that drives cancer-cell survival in resistant tumours.
Final URL
Language
en (html)
Scanned at
2026-06-23 06:05:57